Kardium Revenue and Competitors

CAN

Location

#8947

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Kardium's estimated annual revenue is currently $70.1M per year.(i)
  • Kardium's estimated revenue per employee is $217,000
  • Kardium's total funding is $117M.

Employee Data

  • Kardium has 323 Employees.(i)
  • Kardium grew their employee count by 24% last year.

Kardium's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Global Logistics and Inventory ManagementReveal Email/Phone
3
VP, EngineeringReveal Email/Phone
4
VP, Product ManagementReveal Email/Phone
5
VP, Regulatory Affairs & Quality AssuranceReveal Email/Phone
6
VP TalentReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Director, Quality EngineeringReveal Email/Phone
9
Director Intellectual PropertyReveal Email/Phone
10
Field Clinical Trial Manager, USReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.7M127-5%$132.7MN/A
#2
$8.8M57-7%$2MN/A
#3
$12.9M835%N/AN/A
#4
$10.2M668%N/AN/A
#5
$101.6M468-11%$94.5MN/A
#6
$22.5M2620%$845.8MN/A
#7
$9.8M34-68%$494.1MN/A
#8
$443.8M67311%$371.2MN/A
#9
$27.6M17819%N/AN/A
#10
$82M3788%$871.5MN/A
Add Company

What Is Kardium?

Kardium is developing a revolutionary medical device for the diagnosis and treatment of atrial fibrillation. .

keywords:N/A

$117M

Total Funding

323

Number of Employees

$70.1M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kardium News

2022-04-13 - Pulsed Field Ablation Treats AF With Few Complications

... Intershunt, Javelin, Kardium, Keystone Heart, LuxMed, Manual Surgical Sciences, Medlumics, Middlepeak, Newpace, Nuvera, Sirona Medical,...

2022-04-13 - Kardium's Globe System Begins Clinical Trial at St. Paul's ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Kardium Inc. announces a successful first-in-BC investigational* clinical procedure using the...

2021-01-26 - Kardium Raises $115M in Financing

Kardium Inc., a Vancouver, British Columbia, Canada-based developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, raised US $115m in financing. The round was led by Fidelity Management & Research Company LLC., with participation from funds and accounts advi ...

2021-01-25 - Kardium Announces $115M in New Financing for Innovative Atrial Fibrillation Treatment

Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $115 million in a new financing round. The round is led by Fidelity Management & Research Company LLC., together with follow-on participation by funds and accounts advised by ...

2021-01-25 - BC’s Kardium raises $115 million USD for heart device technology

Kardium, a British Columbia-based medical device company, has secured $115 million USD from Fidelity Management and T. Rowe Price Associates. The round was led by United States-based Fidelity Management, with T. Rowe Price Associates providing follow-on investment after leading Kardium’s $40 mi ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$109M323N/AN/A
#2
$72.7M3232%N/A
#3
$109M323N/AN/A
#4
$64.9M323N/AN/A
#5
$72.7M323N/AN/A